Xenon Pharmaceuticals Inc.
XENE
Pozycja w akcjach
#4599
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company... Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and advancing innovative treatments for individuals living with neurological disorders. The company operates primarily from its headquarters in Burnaby, Canada. Its robust clinical pipeline showcases several promising candidates: XEN496, an activator of Kv7 potassium channels, is currently in Phase III clinical trials for KCNQ2 developmental and epileptic encephalopathy. Another Kv7 potassium channel activator, XEN1101, is progressing through Phase II trials, targeting epilepsy and a range of other neurological conditions. The portfolio also includes NBI-921352, a selective inhibitor of the Nav1.6 sodium channel, which is undergoing Phase II clinical evaluation for SCN8A developmental and epileptic encephalopathy, alongside investigations for adult focal epilepsy and other potential indications. Furthermore, XEN007, a central nervous system-acting calcium channel modulator, is also in Phase II development. Beyond its internal development, Xenon Pharmaceuticals has established strategic collaborations. This includes a licensing and development agreement with Neurocrine Biosciences, Inc. focused on epilepsy treatments, and a partnership with Flexion Therapeutics, Inc. to advance PCRX301 (also known as XEN402), a Nav1.7 inhibitor, for post-operative pain management. Established in 1996, the company continues its mission to address significant unmet medical needs in neurology.
Cena akcji
$34.24
Kapitalizacja rynkowa
$3.32B
Zmiana (1 dzień)
2.24%
Zmiana (1 rok)
-17.75%
Kraj
CA
Handel Xenon Pharmaceuticals Inc. (XENE)
Kategoria
Healthcare
Historia dywidend dla Xenon Pharmaceuticals Inc. (XENE)
Xenon Pharmaceuticals Inc. (symbol giełdowy: XENE) wypłaciła łącznie 0 dywidend.
Suma wszystkich dywidend (skorygowana o podziały akcji): 0.00
Wskaźnik dywidendy (TTM): 0
Suma wszystkich dywidend (skorygowana o podziały akcji): 0.00
Wskaźnik dywidendy (TTM): 0
Wypłaty dywidend dla Xenon Pharmaceuticals Inc. (XENE) od 2026 do 2026
Roczne wypłaty dywidend
| Rok | Dywidenda (skorygowana o podziały akcji) | Zmień |
|---|---|---|
| Za mało danych dla podanych dat. | ||
Lista wszystkich wypłat dywidend
| Rok | Dywidenda | Zmień |
|---|---|---|
| Za mało danych dla podanych dat. | ||
Wypłaty dywidend firm podobnych lub konkurencyjnych
| Firma | Liczba wypłat dywidend | Kraj |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 64.00% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
